| Dr David P Michelin, MD | |
|
217 S Madison Street, Traverse City, MI 49684-2320 | |
| (231) 392-8400 | |
| (231) 935-7888 |
| Full Name | Dr David P Michelin |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 26 Years |
| Location | 217 S Madison Street, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831180140 | NPI | - | NPPES |
| 3476846 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 4301056115 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Munson Healthcare Grayling Hospital | Grayling, MI | Hospital |
| Charlevoix Area Hospital | Charlevoix, MI | Hospital |
| Munson Healthcare Cadillac Hospital | Cadillac, MI | Hospital |
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Medical Center | 3072426287 | 257 |
News Archive
Researchers have designed a subunit vaccine based on the SARS-CoV-2 spike protein co-administered with CpG (Oligodeoxyribonucleotides) adjuvant.
Dr. Steven M. Marcus, executive director of the New Jersey Poison Information & Education System (NJPIES) at UMDNJ-New Jersey Medical School is available to provide comment on the Federal Food and Drug Administration warning issued today on the consumption of products containing pistachios.
Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"
Genzyme Corporation announced today that a Phase 1/2 trial provided early clinical data suggesting that Mozobil (plerixafor injection) in combination with chemotherapy may offer a therapeutic impact on leukemic cells protected in bone marrow.
Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.
› Verified 9 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
Researchers have designed a subunit vaccine based on the SARS-CoV-2 spike protein co-administered with CpG (Oligodeoxyribonucleotides) adjuvant.
Dr. Steven M. Marcus, executive director of the New Jersey Poison Information & Education System (NJPIES) at UMDNJ-New Jersey Medical School is available to provide comment on the Federal Food and Drug Administration warning issued today on the consumption of products containing pistachios.
Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"
Genzyme Corporation announced today that a Phase 1/2 trial provided early clinical data suggesting that Mozobil (plerixafor injection) in combination with chemotherapy may offer a therapeutic impact on leukemic cells protected in bone marrow.
Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David P Michelin, MD 2513 Momentum Pl, Chicago, IL 60689-5325 Ph: (231) 935-6080 | Dr David P Michelin, MD 217 S Madison Street, Traverse City, MI 49684-2320 Ph: (231) 392-8400 |
News Archive
Researchers have designed a subunit vaccine based on the SARS-CoV-2 spike protein co-administered with CpG (Oligodeoxyribonucleotides) adjuvant.
Dr. Steven M. Marcus, executive director of the New Jersey Poison Information & Education System (NJPIES) at UMDNJ-New Jersey Medical School is available to provide comment on the Federal Food and Drug Administration warning issued today on the consumption of products containing pistachios.
Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"
Genzyme Corporation announced today that a Phase 1/2 trial provided early clinical data suggesting that Mozobil (plerixafor injection) in combination with chemotherapy may offer a therapeutic impact on leukemic cells protected in bone marrow.
Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.
› Verified 9 days ago
Diana Lynn Novak, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3960 W Royal Dr, Traverse City, MI 49684 Phone: 231-947-0404 Fax: 231-947-2190 | |
Dr. Laura J Danz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Jennie Rose, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4400 Lands End, Traverse City, MI 49686 Phone: 231-944-4171 | |
Debra Joan Kurtz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0655 Fax: 231-392-0665 | |
Dr. Don A Good, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Douglas L Mckay, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Marcy Verplanck-kanitz, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 |